DIABRISK-SL trial: further consideration of age and impact of imputations

Type 2 diabetes mellitus (T2DM) is a major cause of morbidity and mortality worldwide. Early interventions may help to delay or prevent onset of cardiometabolic endpoints of clinical importance to T2DM patients. Wijesuriya et al. (BMC Med 15:146, 2017) published results of a randomised controlled tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gkioni, Efstathia, Glonti, Ketevan, Dodd, Susanna, Gamble, Carrol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598268/
https://www.ncbi.nlm.nih.gov/pubmed/31248404
http://dx.doi.org/10.1186/s12916-019-1361-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598268/
https://www.ncbi.nlm.nih.gov/pubmed/31248404
http://dx.doi.org/10.1186/s12916-019-1361-2

Ejemplares similares